on Evotec AG (NASDAQ:EVTCY)
Evotec SE Opens J.POD® Biologics Facility in Toulouse, France
Evotec SE, a life sciences company, has officially opened its J.POD® biologics development and manufacturing facility in Toulouse, France. This marks the first European facility for the company's biologics division, Just – Evotec Biologics.
The J.POD® facility introduces scalable, continuous biologics manufacturing technology to Europe, aiming to provide cost-effective and flexible clinical and commercial supply solutions. The opening ceremony saw attendance from local political figures and company executives.
The new 15,000 sqm site, built in 18 months, offers advanced continuous manufacturing technologies. It features dedicated labs for quality control and process development, and emphasizes environmental sustainability by reducing resource usage compared to conventional facilities.
Supported by French government funding and regional economic initiatives, the facility underscores Evotec's commitment to making biotherapeutics more accessible and marks a significant milestone for the company.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news